Christopher B. Eckman
- Physiology top 0.05%
- Alzheimer's disease research and treatments 55
- Neurology top 0.5%
- Biological Psychiatry top 1%
- Pharmacology top 0.1%
- Cholinesterase and Neurodegenerative Diseases 18
- Cellular and Molecular Neuroscience top 0.5%
- Nuclear Receptors and Signaling 9
- Neuroscience and Neuropharmacology Research 6
-
- Prion Diseases and Protein Misfolding 12
- Amyloidosis: Diagnosis, Treatment, Outcomes 7
-
- Drug Transport and Resistance Mechanisms 6
-
- Computational Drug Discovery Methods 6
- Co-authors
- Elizabeth A. EckmanSteven G. YounkinTodd E. GoldeNobuhiro SuzukiLászló ÖtvösRudolph E. TanziAsano OdakaTobun T. Cheung
- Journals
- Journal of Biological Chemistry (11 papers)The FASEB Journal (6 papers)Neurobiology of Aging (6 papers)
- Partner nations
- United StatesJapanSwitzerland
In The Last Decade
Christopher B. Eckman
78 papers receiving 12.3k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Physiology 9.3k
- Neurology 1.5k
- Biological Psychiatry 417
- Pharmacology 2.4k
- Cellular and Molecular Neuroscience 2.3k
Countries citing papers authored by Christopher B. Eckman
This map shows the geographic impact of Christopher B. Eckman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher B. Eckman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher B. Eckman more than expected).
Fields of papers citing papers by Christopher B. Eckman
This network shows the impact of papers produced by Christopher B. Eckman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher B. Eckman. The network helps show where Christopher B. Eckman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher B. Eckman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 32 | |
| 2 | 2011 | 205 | |
| 3 | 2010 | 7 | |
| 4 | 2009 | 19 | |
| 5 | 2008 | 31 | |
| 6 | 2006 | 5 | |
| 7 | 2006 | 165 | |
| 8 | 2006 | 33 | |
| 9 | 2005 | 82 | |
| 10 | 2004 | 202 | |
| 11 | 2004 | 221 | |
| 12 | 2004 | 51 | |
| 13 | 2004 | 230 | |
| 14 | 2004 | 67 | |
| 15 | Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivobreakdown → | 2003 | 1191 |
| 16 | 2003 | 64 | |
| 17 | The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formationbreakdown → | 2001 | 943 |
| 18 | 2001 | 126 | |
| 19 | 1999 | 45 | |
| 20 | Amyloid β Protein (Aβ) in Alzheimeri's Disease Brainbreakdown → | 1995 | 553 |
About Christopher B. Eckman
Christopher B. Eckman is a scholar working on Physiology, Cellular and Molecular Neuroscience and Pharmacology, having authored 78 papers that have together received 12.6k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (55 papers), Cholinesterase and Neurodegenerative Diseases (18 papers), Prion Diseases and Protein Misfolding (12 papers), Nuclear Receptors and Signaling (9 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Drug Transport and Resistance Mechanisms (6 papers), Neuroscience and Neuropharmacology Research (6 papers) and Computational Drug Discovery Methods (6 papers). The work is most often cited by research in Physiology (9.3k citations), Neurology (1.5k citations) and Biological Psychiatry (417 citations). Christopher B. Eckman has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Elizabeth A. Eckman, Steven G. Younkin, Todd E. Golde, Nobuhiro Suzuki, László Ötvös, Rudolph E. Tanzi, Asano Odaka, Tobun T. Cheung, Dennis J. Selkoe and Wesley Farris. Their work appears in journals such as Journal of Biological Chemistry, The FASEB Journal, Neurobiology of Aging, Neuron and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.